{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:41:26Z","timestamp":1792078886858,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":1429,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1017\/s1041610220000903","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T03:31:25Z","timestamp":1593487885000},"page":"179-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A systematic review of ketamine for the treatment of depression among older adults"],"prefix":"10.1016","volume":"33","author":[{"given":"Aarti","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romika","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Patadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Funaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda A.","family":"Farheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh R.","family":"Tampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610220000903_bb0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/nyas.12718","article-title":"Ketamine as a promising prototype for a new generation of rapid-acting antidepressants","volume":"1344","author":"Abdallah","year":"2015","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1017\/S1041610220000903_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/YCT.0b013e31824f8296","article-title":"Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting","volume":"28","author":"Abdallah","year":"2012","journal-title":"Journal of ECT"},{"key":"10.1017\/S1041610220000903_rf0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41398-019-0514-6","article-title":"Mechanisms and treatment of late-life depression","volume":"9","author":"Alexopoulos","year":"2019","journal-title":"Translational Psychiatry"},{"key":"10.1017\/S1041610220000903_rf0025","first-page":"674","article-title":"Updated AGS beers criteria(R) for potentially inappropriate medication use in older adults","volume":"67","author":"American Geriatrics Society","year":"2019","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610220000903_bb0030","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.4088\/JCP.17f11738","article-title":"Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency?","volume":"78","author":"Andrade","year":"2017","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1176\/appi.ps.201100078","article-title":"Implementing evidence-based psychotherapies in settings serving older adults: challenges and solutions","volume":"63","author":"Arean","year":"2012","journal-title":"Psychiatric Services"},{"key":"10.1017\/S1041610220000903_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4088\/PCC.v09n0606","article-title":"Anxiety, depression, and quality of life in primary care patients","volume":"9","author":"Brenes","year":"2007","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jfma.2011.11.010","article-title":"Ketamine-snorting associated cystitis","volume":"110","author":"Chen","year":"2011","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1017\/S1041610220000903_bb0055","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatry Research"},{"key":"10.1017\/S1041610220000903_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0253-7176.127258","article-title":"Acute antidepressant effects of intramuscular versus intravenous ketamine","volume":"36","author":"Chilukuri","year":"2014","journal-title":"Indian Journal of Psychological Medicine"},{"key":"10.1017\/S1041610220000903_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry."},{"key":"10.1017\/S1041610220000903_bb0075","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/0004867414520754","article-title":"Oral ketamine augmentation for chronic suicidality in treatment-resistant depression","volume":"48","author":"De Gioannis","year":"2014","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0080","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/da.22772","article-title":"Predictors of recurrence in remitted late-life depression","volume":"35","author":"Deng","year":"2018","journal-title":"Depression & Anxiety"},{"key":"10.1017\/S1041610220000903_bb0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/20961790.2017.1285219","article-title":"Metabolism and metabolomics of ketamine: a toxicological approach","volume":"2","author":"Dinis-Oliveira","year":"2017","journal-title":"Forensic Sciences Research"},{"key":"10.1017\/S1041610220000903_bb0095","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger. 1965","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1017\/S1041610220000903_bb0100","unstructured":"Fda. Gov. Esketamine [Online]. Available at https:\/\/www.fda.gov\/media\/121379\/download; last accessed 29 April 2020."},{"key":"10.1017\/S1041610220000903_bb0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1017\/S1041610220000903_bb0110","unstructured":"Food and Drug Administration. (2019). FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor\u2019s office or clinic [Online]. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified; last accessed 2 September 2019."},{"key":"10.1017\/S1041610220000903_bb0115","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"Journal of Gerontology Series A: Biological Sciences and Medical Sciences"},{"key":"10.1017\/S1041610220000903_bb0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11920-016-0674-5","article-title":"Electroconvulsive therapy in the elderly: new findings in geriatric depression","volume":"18","author":"Geduldig","year":"2016","journal-title":"Current Psychiatry Reports"},{"key":"10.1017\/S1041610220000903_bb0125","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jagp.2017.06.007","article-title":"Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression","volume":"25","author":"George","year":"2017","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0130","author":"Grossetta Nardini"},{"key":"10.1017\/S1041610220000903_bb0135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/jpm.2013.0057","article-title":"Case report: long-term mood response to repeat dose intramuscular ketamine in a depressed patient with advanced cancer","volume":"16","author":"Grott Zanicotti","year":"2013","journal-title":"Journal of Palliative Medicine"},{"key":"10.1017\/S1041610220000903_bb0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-017-4786-3","article-title":"Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study","volume":"235","author":"Hartberg","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1017\/S1041610220000903_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0009-9236(95)90194-9","article-title":"Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers","volume":"58","author":"Hartvig","year":"1995","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1017\/S1041610220000903_bb0150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1055\/s-2007-994851","article-title":"The clinical use of S-(+)-ketamine \u2013 a determination of its place","volume":"33","author":"Himmelseher","year":"1998","journal-title":"Anasthesiology Intensivmed Notfallmed Schmerzther"},{"key":"10.1017\/S1041610220000903_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1017\/S1041610220000903_bb0160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/YCT.0b013e318283b7e9","article-title":"Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study","volume":"29","author":"Jarventausta","year":"2013","journal-title":"Journal of ECT"},{"key":"10.1017\/S1041610220000903_bb0165","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/npp.2013.149","article-title":"Relapse following successful electroconvulsive therapy for major depression: a meta-analysis","volume":"38","author":"Jelovac","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1017\/S1041610220000903_bb0170","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00127-015-1019-0","article-title":"Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide","volume":"50","author":"Jia","year":"2015","journal-title":"Social Psychiatry and Psychiatry Epidemiology"},{"key":"10.1017\/S1041610220000903_bb0175","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerging Health Threats Journal"},{"key":"10.1017\/S1041610220000903_bb0180","first-page":"1186","article-title":"Ketamine: teaching an old drug new tricks","volume":"87","author":"Kohrs","year":"1998","journal-title":"Anesthesia Research Analgesia"},{"key":"10.1017\/S1041610220000903_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2019.07.130","article-title":"Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: a systematic review, pairwise and network meta-analysis","author":"Krause","year":"2019","journal-title":"European Neuropsychopharmacology."},{"key":"10.1017\/S1041610220000903_bb0190","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/15622975.2014.922697","article-title":"Pilot dose-response trial of i.v. ketamine in treatment-resistant depression","volume":"15","author":"Lai","year":"2014","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0195","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1017\/S1461145713000485","article-title":"Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression","volume":"16","author":"Lara","year":"2013","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1017\/S1041610220000903_bb0200","first-page":"340","article-title":"Antidepressants in the elderly","volume":"65","author":"Lindblad","year":"2019","journal-title":"Canadian Family Physician"},{"key":"10.1017\/S1041610220000903_bb0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Research Bulletin"},{"key":"10.1017\/S1041610220000903_bb0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/acps.12572","article-title":"Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","volume":"134","author":"Loo","year":"2016","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610220000903_bb0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11599770-000000000-00000","article-title":"Ketamine for treatment-resistant unipolar depression: current evidence","volume":"26","author":"Mathew","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1017\/S1041610220000903_bb0220","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4088\/JCP.13ac08382","article-title":"Current status of ketamine and related compounds for depression","volume":"74","author":"Mathews","year":"2013","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1017\/S1041610220000903_bb0230","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.JGP.0000308883.64832.ed","article-title":"Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence","volume":"16","author":"Nelson","year":"2008","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0235","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1532-5415.2011.03355.x","article-title":"A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia","volume":"59","author":"Nelson","year":"2011","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610220000903_bb0240","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jagp.2019.10.008","article-title":"Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression-TRANSFORM-3","volume":"28","author":"Ochs-Ross","year":"2020","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-0029-1237375","article-title":"Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series","volume":"43","author":"Paslakis","year":"2010","journal-title":"Pharmacopsychiatry"},{"key":"10.1017\/S1041610220000903_bb0255","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","volume":"55","author":"Peltoniemi","year":"2016","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1017\/S1041610220000903_bb0260","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1176\/ajp.2006.163.9.1493","article-title":"Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy","volume":"163","author":"Pinquart","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11920-017-0812-8","article-title":"Advances in psychotherapy for depressed older adults","volume":"19","author":"Raue","year":"2017","journal-title":"Current Psychiatry Reports"},{"key":"10.1017\/S1041610220000903_bb0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/wps.20193","article-title":"Prevalence of psychiatric disorders in US older adults: findings from a nationally representative survey","volume":"14","author":"Reynolds","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0275","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jagp.2014.05.002","article-title":"Older age is associated with rapid remission of depression after electroconvulsive therapy: a latent class growth analysis","volume":"23","author":"Rhebergen","year":"2015","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0280","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/gerona\/glx215","article-title":"12 year trajectories of depressive symptoms in community-dwelling older adults and the subsequent risk of death over 13 years","volume":"73","author":"Saeed Mirza","year":"2018","journal-title":"Journal of Gerontology Series A: Biological Sciences and Medical Sciences"},{"key":"10.1017\/S1041610220000903_bb0285","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13607863.2015.1055552","article-title":"Suicide rates in five-year age-bands after the age of 60 years: the international landscape","volume":"20","author":"Shah","year":"2016","journal-title":"Aging & Mental Health"},{"key":"10.1017\/S1041610220000903_bb0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1017\/S1041610220000903_bb0300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1192\/bjp.bp.114.148213","article-title":"Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication","volume":"206","author":"Spaans","year":"2015","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0305","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4088\/JCP.10r06531","article-title":"Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials","volume":"72","author":"Tedeschini","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0310","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12888-015-0641-4","article-title":"Study protocol for the randomised controlled trial: ketamine augmentation of ECT to improve outcomes in depression (ketamine-ECT study)","volume":"15","author":"Trevithick","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0315","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12872-015-0036-y","article-title":"Depression increases the onset of cardiovascular disease over and above other determinants in older primary care patients, a cohort study","volume":"15","author":"Van Marwijk","year":"2015","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1017\/S1041610220000903_bb0320","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/JCP.0000000000000960","article-title":"Efficacy and safety of a rapid intravenous injection of ketamine 0.5 mg\/kg in treatment-resistant major depression: an open 4-week longitudinal study","volume":"38","author":"Vidal","year":"2018","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1017\/S1041610220000903_bb0325","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1989.03430070062031","article-title":"The functioning and well-being of depressed patients. Results from the medical outcomes study","volume":"262","author":"Wells","year":"1989","journal-title":"JAMA"},{"key":"10.1017\/S1041610220000903_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004853.pub2","article-title":"Psychotherapeutic treatments for older depressed people","author":"Wilson","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610220000903_bb0335","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.301.2.690","article-title":"Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action","volume":"301","author":"Winger","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1017\/S1041610220000903_bb0340","unstructured":"World Health Organization. (2017). Mental health of older adults [Online]. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-health-of-older-adults; last accessed 2 September 2019."},{"key":"10.1017\/S1041610220000903_bb0345","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.336","article-title":"Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers","volume":"24","author":"Yanagihara","year":"2003","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"10.1017\/S1041610220000903_bb0350","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/YCT.0b013e3182a4b4c6","article-title":"Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study","volume":"30","author":"Yoosefi","year":"2014","journal-title":"Journal of ECT"},{"key":"10.1017\/S1041610220000903_bb0355","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Molecular Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0360","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine\u2019s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1017\/S1041610220000903_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2017.09.022","article-title":"Depression and cardiovascular disease in elderly: current understanding","volume":"47","author":"Zhang","year":"2018","journal-title":"Journal of Clinical Neuroscience"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224036524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224036524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610220000903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T08:55:22Z","timestamp":1736412922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224036524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1041610224036524"],"URL":"https:\/\/doi.org\/10.1017\/s1041610220000903","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of ketamine for the treatment of depression among older adults","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610220000903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Psychogeriatric Association 2020. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}